We are live on
!
Find out more
Jasper Ridge Partners Portfolio holdings
AUM
$4.69B
Turnover
13.92%
1-Year Est. Return
31.34%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+31.34%
3 Year Est. Return
+84.21%
5 Year Est. Return
+70.25%
10 Year Est. Return
+324.79%
AUM
$1.26B
AUM Growth
-$421M
(-25%)
Cap. Flow
-$442M
Cap. Flow
% of AUM
-35.25%
Top 10 Holdings %
Top 10 Hldgs %
88.26%
Holding
72
New
9
Increased
9
Reduced
11
Closed
3
Avg Time Held
2.3
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Denali Therapeutics
DNLI
|
+$5.3M |
| 2 |
AQ
Aquantia Corp. Common Stock
AQ
|
+$3.55M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$2.81M |
| 4 |
Salesforce
CRM
|
+$996K |
| 5 |
ServiceNow
NOW
|
+$852K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$245M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$62.3M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$59.4M |
| 4 |
R1 RCM Inc. Common Stock
RCM
|
+$39.9M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$34.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 77.38% |
| 2 | Communication Services | 9.78% |
| 3 | Consumer Discretionary | 5.64% |
| 4 | Technology | 3.64% |
| 5 | Industrials | 2.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Alarm.com
ALRM
$2.83B
| $492K | 0.04% |
12,175
+4,721
| +63% | +$196K |
2017 Q3
3 quarters
|
|
52
iShares MSCI ACWI ETF
ACWI
$32.9B
| $418K | 0.03% |
5,882
-7,538
| -56% | -$547K |
2015 Q1
13 quarters
|
|
|
CLVS
53
DELISTED
Clovis Oncology, Inc.
CLVS
| $418K | 0.03% |
9,184
| – | – |
2016 Q4
6 quarters
|
|
54
Natera
NTRA
$58.3B
| $406K | 0.03% |
21,574
| – | – |
2016 Q2
8 quarters
|
|
55
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.6B
| $389K | 0.03% |
1,095
| – | – |
2015 Q4
10 quarters
|
|
56
Vanguard FTSE All-World ex-US ETF
VEU
$67.4B
| $389K | 0.03% |
7,510
| – | – |
2015 Q4
10 quarters
|
|
57
DELISTED
Esperion Therapeutics
ESPR
| $383K | 0.03% |
9,773
| – | – |
2017 Q4
2 quarters
|
|
58
DELISTED
Redfin
RDFN
| $373K | 0.03% |
+16,170
| New | +$364K |
2018 Q2
0 quarters
|
|
59
Workday
WDAY
$47.4B
| $364K | 0.03% |
3,003
| – | – |
2013 Q2
20 quarters
|
|
60
CRISPR Therapeutics
CRSP
$4.98B
| $322K | 0.03% |
+5,484
| New | +$312K |
2018 Q2
0 quarters
|
|
61
DELISTED
Asensus Surgical, Inc.
ASXC
| $302K | 0.02% |
+5,325
| New | +$194K |
2018 Q2
0 quarters
|
|
|
AIMT
62
DELISTED
Aimmune Therapeutics
AIMT
| $279K | 0.02% |
10,385
| – | – |
2017 Q4
2 quarters
|
|
|
CRCM
63
DELISTED
CARE.COM, INC.
CRCM
| $274K | 0.02% |
13,115
| – | – |
2017 Q4
2 quarters
|
|
|
IMMU
64
DELISTED
Immunomedics Inc
IMMU
| $259K | 0.02% |
+10,924
| New | +$220K |
2018 Q2
0 quarters
|
|
65
Senseonics Holdings Inc
SENS
$435M
| $248K | 0.02% |
3,019
| – | – |
2017 Q4
2 quarters
|
|
66
Qualcomm
QCOM
$191B
| $247K | 0.02% |
4,400
| – | – |
2013 Q2
20 quarters
|
|
67
iShares Core US Aggregate Bond ETF
AGG
$138B
| $231K | 0.02% |
2,174
+15
| +0.7% | +$1.59K |
2017 Q1
5 quarters
|
|
|
DATA
68
DELISTED
Tableau Software, Inc.
DATA
| $219K | 0.02% |
+2,237
| New | +$205K |
2018 Q2
0 quarters
|
|
|
MITL
69
DELISTED
Mitel Networks Corporation
MITL
| $153K | 0.01% |
13,988
| – | – |
2017 Q4
2 quarters
|
|
|
TSRO
70
DELISTED
TESARO, Inc.
TSRO
| – | – |
-4,028
| Closed | -$230K | – |
|
|
MON
71
DELISTED
Monsanto Co
MON
| – | – |
-7,600
| Closed | -$887K | – |
|
|
MULE
72
DELISTED
MuleSoft, Inc.
MULE
| – | – |
-17,616
| Closed | -$775K | – |
|
Similar funds
TCIM
Jasper Ridge Partners's Q2 2018 Portfolio in Review
As of Q2 2018, Jasper Ridge Partners held 72 positions worth $1.26B, down 25% from $1.68B the previous quarter. Its ten largest holdings account for 88% of the portfolio.
Jasper Ridge Partners withdrew a net $442M in Q2 2018, closing 3 positions and reducing 11 holdings. Its most notable exit was Monsanto Co, an estimated $887K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, down from 84% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Jasper Ridge Partners opened a new position in Denali Therapeutics worth $4.29M.
- Jasper Ridge Partners's largest Q2 2018 buy was Denali Therapeutics: 281,250 shares worth $4.29M.
- Jasper Ridge Partners added most to Alphabet (Google) Class C in Q2 2018, an estimated $2.81M increase.
- Jasper Ridge Partners's biggest Q2 2018 reduction was iShares Core S&P 500 ETF, cutting an estimated $245M.
- Jasper Ridge Partners fully exited Monsanto Co in Q2 2018, selling an estimated $887K.
- Jasper Ridge Partners's ten largest holdings make up 88% of its $1.26B portfolio in Q2 2018.
- Jasper Ridge Partners opened 9 new positions and closed 3 in Q2 2018.
- Jasper Ridge Partners's portfolio value fell 25% quarter-over-quarter to $1.26B.
Based on Jasper Ridge Partners's 13F filing for Q2 2018, filed 13 Aug 2018.